ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,560Medicare Part D Prescriptions Filled, Including Refills

Rank: 90 out of 2604

$529K Total Retail Price of All Prescriptions

Rank: 178 out of 2604

331 Patients Receiving at Least One Drug in Part D
53%Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

9% of this provider’s 331 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 5,412 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
LEVOTHYROXINE SODIUM 588 261 1 4
OMEPRAZOLE 356 192 2 5
POLYETHYLENE GLYCOL 3350 335 124 3 42
LISINOPRIL 276 163 4 3
SIMVASTATIN 266 152 5 2
FUROSEMIDE 257 232 6 8
OXYBUTYNIN CHLORIDE 221 117 7 92
RANITIDINE HCL 221 106 7 25
AMLODIPINE BESYLATE 213 121 9 6
POTASSIUM CHLORIDE 192 147 10 16
HYDROCHLOROTHIAZIDE 178 56 11 10
METFORMIN HCL 169 75 12 7
ATORVASTATIN CALCIUM 154 74 13 19
GABAPENTIN 153 97 14 12
ALLOPURINOL 147 92 15 35
METOPROLOL TARTRATE 141 81 16 9
LOVAZA 121 19 17 146
FENOFIBRATE 119 0 18 69
SPIRIVA 114 75 19 45
ZOLPIDEM TARTRATE 104 76 20 21
TAMSULOSIN HCL 98 59 21 30
TRICOR 97 61 22 132
PROAIR HFA 97 14 22 27
PHENYTOIN SODIUM EXTENDED 96 23 24 135
ALENDRONATE SODIUM 95 74 25 29
ATENOLOL 94 76 26 11
HYDROXYZINE HCL 94 41 R 26 214
TRAMADOL HCL 93 62 28 15
HYDROCODONE-ACETAMINOPHEN 93 74 S3 28 1
TRAZODONE HCL 88 61 30 46
GEMFIBROZIL 85 0 31 87
CARVEDILOL 80 59 32 26
CARBAMAZEPINE 79 0 33 182
SULFAMETHOXAZOLE-TRIMETHOPRIM 76 49 34 91
DIVALPROEX SODIUM 76 0 34 81
RISPERIDONE 74 38 36 65
METOPROLOL SUCCINATE 72 57 37 17
CITALOPRAM HBR 71 42 38 18
ADVAIR DISKUS 70 31 39 41
COMBIVENT 70 47 39 169
LEVETIRACETAM 70 22 39 96
PRAVASTATIN SODIUM 70 51 39 14
NEOMYCIN-POLYMYXIN-HC 69 27 43 436
PAROXETINE HCL 68 33 44 62
SERTRALINE HCL 64 17 45 23
LACTULOSE 63 0 46 108
NEXIUM 61 22 47 53
CYCLOBENZAPRINE HCL 61 21 R 47 43
NYSTATIN 59 32 49 100
LANTUS SOLOSTAR 56 30 50 84
FAMOTIDINE 56 21 50 68
LISINOPRIL-HYDROCHLOROTHIAZIDE 56 38 50 22
LIPITOR 55 25 53 225
DONEPEZIL HCL 53 35 54 28
PROPRANOLOL HCL 52 0 55 154
CELEBREX 52 23 55 114
PREDNISONE 51 39 57 34
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 11, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.